Cloned enzyme donor immunoassay (CEDIA) for drugs-of-abuse screening.
Large numbers of specimens (5000-18,000) were screened for amphetamines, barbiturates, cocaine, marijuana, opiates, and phencyclidine by RIA (Roche), Emit II (Syva), and a new immunoassay, CEDIA (cloned enzyme donor immunoassay, Microgenics). All immunoassays performed equivalently for cocaine, opiates, and phencyclidine. All immunoassays detected the same amphetamine/methamphetamine-positive specimens, but all also detected numerous specimens containing cross-reacting sympathomimetic amines. CEDIA detected 100%, Emit II 93%, and RIA 82% of the barbiturate-positive specimens. Emit II and CEDIA detected 86-88% of the specimens found by RIA to be marijuana positive. A subset of specimens was additionally screened by OnLine (Roche) and TDx (Abbott) for amphetamines, cocaine, and marijuana. OnLine and TDx also detected all of the amphetamine-positive specimens and numerous specimens containing cross-reacting sympathomimetic amines. All immunoassays performed equivalently for cocaine, and the four nonisotopic tests detected 86-89% of the marijuana positives found by RIA. Interfering sympathomimetic amine drug compounds can be eliminated by using an oxidizing agent, thus decreasing the number of unconfirmable amphetamine presumptive positives. The CEDIAs for all of the major drugs of abuse are reliable and effective for large-volume urine screening programs.
Armbruster
D A
DA
Armstrong Laboratory Drug Testing Division, Human Systems Center (AFMC), Brooks AFB, TX 78235-3219.
Hubster
E C
EC
Kaufman
M S
MS
Ramon
M K
MK
D000662:Amphetamines / Q000652:urine; D001463:Barbiturates / Q000652:urine; D002186:Cannabinoids / Q000652:urine; D003042:Cocaine / Q000652:urine; D017248:Enzyme Multiplied Immunoassay Technique; D005690:Galactose; D006801:Humans; D007124:Immunoenzyme Techniques / Q000706:statistics & numerical data; D009294:Narcotics / Q000652:urine; D010622:Phencyclidine / Q000652:urine; D011863:Radioimmunoassay; D012680:Sensitivity and Specificity; D015813:Substance Abuse Detection / Q000379:methods*; D001616:beta-Galactosidase
D000662:Amphetamines; D001463:Barbiturates; D002186:Cannabinoids; D009294:Narcotics; D001616:beta-Galactosidase; D003042:Cocaine; D010622:Phencyclidine; D005690:Galactose